Pulmonary complications of sickle cell disease in children

Jason B Caboot1, Julian L Allen

  • 1Division of Pulmonary Medicine and Cystic Fibrosis Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4399, USA.

Insights

Sickle cell disease (SCD) significantly impacts lung health in children, leading to conditions like asthma, acute chest syndrome, and pulmonary hypertension. Understanding these pulmonary complications is crucial for improving treatment strategies and patient outcomes.

Area of Science:

  • Pulmonary Medicine
  • Pediatric Hematology
  • Genetics

Background:

  • Sickle cell disease (SCD) is a prevalent genetic disorder affecting 1 in 600 African-Americans.
  • The lungs are a primary target organ in SCD, contributing to significant childhood morbidity and mortality.
  • Pulmonary complications are a major concern for children with SCD.

Purpose of the Study:

  • To review recent literature on pulmonary complications in pediatric sickle cell disease.
  • To highlight the associations between SCD and various respiratory conditions.
  • To emphasize the need for further research into the interrelationships of these pulmonary issues.

Main Methods:

  • Literature review of recent studies on sickle cell disease and pulmonary manifestations.
  • Synthesis of evidence linking asthma, airway hyperreactivity, acute chest syndrome, and pulmonary hypertension with SCD.
  • Analysis of findings related to sleep-disordered breathing in children with SCD.

Main Results:

  • Strong associations found between asthma, airway hyperreactivity, and SCD.
  • Acute chest syndrome (ACS) in SCD is linked to worse pulmonary function and vaso-occlusive crisis.
  • Pulmonary hypertension and sleep-disordered breathing are increasingly recognized in children with SCD.

Conclusions:

  • Key pulmonary complications in SCD include airway hyperreactivity, ACS, chronic sickle lung disease, pulmonary hypertension, and sleep-disordered breathing.
  • Understanding the interplay between these conditions is vital for developing effective therapies.
  • Further research is needed to elucidate the mechanisms and improve management of pulmonary issues in pediatric SCD.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...